Legal status · United States
Is Bimagrumab legal in the United States?
No. Bimagrumab is not approved for any medical use in the United States; its classification is "Investigational, not approved". Lawful access is limited to registered clinical trials. "Research use only" labeling on vials sold online does not make human use lawful. Human evidence to date: Moderate.
Bimagrumab in the United States at a glance
| Classification | Investigational, not approved |
|---|---|
| FDA approval status | Investigational for obesity / body composition; Phase 2 BELIEVE published 2026 |
| Evidence level | Moderate (research strength: Moderate) |
| Reviewed | Sep 2026 |
Classification and note come from the Bimagrumab profile, checked against U.S. Food and Drug Administration (FDA) listings at the reviewed date.
What this means
- 01
Bimagrumab is being studied in registered clinical trials but has not received FDA marketing approval in the United States.
- 02
Lawful human access is limited to trial participation or a formal early-access scheme where one exists; there is no pharmacy product to prescribe.
- 03
Vials sold online "for research use only" are not trial material, and that label does not make human use lawful.
What Bimagrumab is
A muscle-preserving antibody that blocks activin receptors to reduce fat while increasing lean mass, being studied alongside GLP-1 drugs.
Bimagrumab is a monoclonal antibody that blocks activin type II receptors, releasing the brake on muscle growth. In trials it reduced body fat while increasing lean muscle mass, an unusual profile for a weight-loss agent.
Mechanism: Blocks activin type II receptors, neutralizing myostatin and activin signaling to build muscle and reduce fat mass.
Regulatory history: Investigational for obesity / body composition; Phase 2 BELIEVE published 2026
How FDA treats this kind of product
Approves prescription drugs by indication and polices unapproved products, including peptides sold online. Compounding pharmacies may prepare some compounds under a prescription when the FDA places them on a permitted bulk-substances category.
The classification above is the The Longevity Archive reading of U.S. Food and Drug Administration listings for Bimagrumab at the reviewed date, not a legal opinion. Rules change, and importing, prescribing and possessing a compound can each be treated differently. Check the regulator directly before acting on anything here.
Bimagrumab in other countries
Frequently asked questions
Is Bimagrumab legal in the United States?
No. Bimagrumab is not approved for any medical use in the United States; its classification is "Investigational, not approved". Lawful access is limited to registered clinical trials. "Research use only" labeling on vials sold online does not make human use lawful. Human evidence to date: Moderate.
Can I buy Bimagrumab in the United States?
No approved product exists to buy. In the United States Bimagrumab is classified as "Investigational, not approved", so there is no licensed pharmacy product. Vendors selling it "for research use only" are not selling it for human use, and that label does not change its legal status. This site does not list or recommend vendors.
Is Bimagrumab FDA approved?
No. FDA status: Investigational for obesity / body composition; Phase 2 BELIEVE published 2026. Current US classification: "Investigational, not approved". Evidence level: Moderate.
Related compounds in the United States
Full research profile
Mechanism, cited studies, FDA status and the full legal summary for Bimagrumab live on its compound profile.
Bimagrumab profileThis page is general information about the regulatory status of Bimagrumab in the United States, current as of Sep 2026. It is not legal advice, and classifications change; check U.S. Food and Drug Administration directly or consult a lawyer for a specific situation. Educational use only. This database summarizes published research. It is not medical advice and contains no dosing protocols or recommendations for personal use. The Longevity Archive has no vendor relationships and does not recommend where to buy anything.